SynopsisIn this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites The global Communicable Diseases Treatment market size is expected to reach US$ 68580 mil.....
SynopsisThe increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the market during the study period. The global Nerve Monitoring S.....
SynopsisThe global Covid-19 Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at.....
SynopsisVenous blood collection devices are vessels used for collection, sampling, and testing blood samples. The global Venous Blood Collection Devices market was valued at US$ 3797.6 million in 2023 and is anticipated to reach US$ 4594.9 million by 2030, witne.....
SynopsisNeuraminidase enzymes are glycoside hydrolase enzymes that cleave (cut) the glycosidic linkages of neuraminic acids. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus. The global Influenza .....
SynopsisDental caries is one of the most common dental diseases. It is a condition of tooth decay and cavity formation where this condition is caused by specific types of bacteria. These bacteria create acid that destroys tooth enamel and dentin, the layer under it, f.....
SynopsisThe global Ophthalmic Viscoelastic Agent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devic.....
SynopsisGlucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have .....
SynopsisGlobal Aeromonas Aminopeptidase Recombinant Protein market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russ.....
SynopsisGlobal Veterinary Doppler Ultrasound System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukrai.....
